Company Analysis
Sign in

CDT Equity Inc. (CDT)

Nasdaq: CDT · Pharmaceutical Preparations · Naples, FL · filing with the SEC since 2021
Full chart Alerts Compare
Grade3.3
◀ Past 2.5● Present 1.8▶ Future 5.0
6 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart
The companyfiscal 2025, as filed
Revenuen/a
Net income-$39.2M-120.3%
Earnings per share$-1177.89+98.1%
Operating cash flow-$15.6M-60.7%
Cash$1.5M+172.4%
Debtn/a
Shareholders’ equity-$7.2M-5.5%
Shares, diluted33,300+11422.5%
Return on equityn/a
The recordfrom its filings
Filings in 202690
Newest filingNov 9 · 424B3
Annual reportApr 15, 2026
Quarterly reportAug 12, 2026
Next report due10-Q by Nov 14
Insider sales, 12 months$0.00
Insider buys, 12 months$0.00
Patents grantedn/a
Filer category<br>Emerging growth company
Trailing twelve months to Jun 2026Net income -$37.1MCash from operations -$11.5Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
22232425
As filed, in USD. Nothing here is a forecast.

News

Nov 9, 2026 · SEC EDGAR · Form 424B3
Shelf offering
Open the filing on sec.gov
Nov 9, 2026 · SEC EDGAR · Form 8-K
Current report
Open the filing on sec.gov
Nov 4, 2026 · SEC EDGAR · Form 424B3
Shelf offering
Open the filing on sec.gov
Nov 4, 2026 · SEC EDGAR · Form 8-K
Current report
Open the filing on sec.gov
Nov 3, 2026 · SEC EDGAR · Form 424B3
Shelf offering
Open the filing on sec.gov
Oct 27, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton CDT · research, not advice